arrow
返回

HIF hydroxylase inhibitors decrease cellular oxygen consumption depending on their selectivity

delete2019-12-19
delete24
PRE
AI
P
Pascale Sulser
C
Christina Pickel
J
Julia Günter
T
T.M. Leissing
D
Daniel Crean
C
Christopher J. Schofield
R
Roland H. Wenger
C
Carsten C. Scholz *
DOI:10.1096/fj.201902240Rdelete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
Pharmacologic HIF hydroxylase inhibitors (HIs) are effective for the treatment of anemia in chronic kidney disease patients and may also be beneficial for the treatment of diseases such as chronic inflammation and ischemia-reperfusion injury. The selectivities of many HIs for HIF hydroxylases and possible off-target effects in cellulo are unclear, delaying the translation from preclinical studies to clinical trials. We developed a novel assay that discriminates between the inhibition of HIF-alpha prolyl-4-hydroxylase domain (PHD) enzymes and HIF-alpha asparagine hydroxylase factor inhibiting HIF (FIH). We characterized 15 clinical and preclinical HIs, categorizing them into pan-HIF-alpha hydroxylase (broad spectrum), PHD-selective, and FIH-selective inhibitors, and investigated their effects on HIF-dependent transcriptional regulation, erythropoietin production, and cellular energy metabolism. While energy homeostasis was generally maintained following HI treatment, the pan-HIs led to a stronger increase in pericellular pO(2) than the PHD/FIH-selective HIs. Combined knockdown of FIH and PHD-selective inhibition did not further increase pericellular pO(2). Hence, the additional increase in pericellular pO(2) by pan- over PHD-selective HIs likely reflects HIF hydroxylase independent off-target effects. Overall, these analyses demonstrate that HIs can lead to oxygen redistribution within the cellular microenvironment, which should be considered as a possible contributor to HI effects in the treatment of hypoxia-associated diseases.
Keyword:
anemia
hypoxia
2-oxoglutarate oxygenase inhibitor
prolyl hydroxylase inhibitor
Roxadustat
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

FASEB Journal 封面图
FASEB Journal
IF:
4.2
论文数:
3.1W
被引数:
4.9W

机构

U
university of zurich
学者数:
5.1W
论文数: 4.0W
被引数: 65
U
university college dublin
学者数:
2.6W
论文数: 2.2W
被引数: 22
引用论文

引用论文

Lipoproteins of Enterococcus faecalis: bioinformatic identification, expression analysis and relation to virulence
err2011-11-01
err0
PREAI
errFany Reffuveille; Charlène Leneveu; Sylvie Chevalier; Yanick Auffray; Alain Rincé
err分享
err收藏
err分享
err收藏
Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases
err2014-10-31
err307
errOAAI
errEltzschig, Holger K.; Bratton, Donna L.; Colgan, Sean P.
err分享
err收藏
Mechanisms of resistance to EGFR-targeted drugs: lung cancer
err2016-01-01
err0
errOAAI
errFloriana Morgillo; Carminia Maria Della Corte; Morena Fasano; Fortunato Ciardiello
err分享
err收藏
Oxygen-dependent bond formation with FIH regulates the activity of the client protein OTUB1
err2019-09-01
err17
errOAAI
errPickel, Christina; Gunter, Julia; Ruiz-Serrano, Amalia; Spielmann, Patrick; Fabrizio, Jacqueline-Alba; Wolski, Witold; Peet, Daniel J.; Wenger, Roland H.; Scholz, Carsten C.
err分享
err收藏
Generation of renal Epo-producing cell lines by conditional gene tagging reveals rapid HIF-2 driven Epo kinetics, cell autonomous feedback regulation, and a telocyte phenotype
err2019-02-01
err44
errOAAI
errImeri, Faik; Nolan, Karen A.; Bapst, Andreas M.; Santambrogio, Sara; Abreu-Rodriguez, Irene; Spielmann, Patrick; Pfundstein, Svende; Libertini, Silvana; Crowther, Lisa; Orlando, Ilaria M. C.; Dahl, Sophie L.; Keodara, Anna; Kuo, Willy; Kurtcuoglu, Vartan; Scholz, Carsten C.; Qi, Weihong; Hummler, Edith; Hoogewijs, David; Wenger, Roland H.
err分享
err收藏
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
err2002-09-26
err577
errOAAI
errIvan, M; Haberberger, T; Gervasi, DC; Michelson, KS; Günzler, V; Kondo, K; Yang, HF; Sorokina, I; Conaway, RC; Conaway, JW; Kaelin, WG
err分享
err收藏
The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases
err2019-07-09
err27
errOAAI
errRoatsch, Martin; Hoffmann, Inga; Abboud, Martine, I; Hancock, Rebecca L.; Tarhonskaya, Hanna; Hsu, Kuo-Feng; Wilkins, Sarah E.; Yeh, Tzu-Lan; Lippl, Kerstin; Serrer, Kerstin; Moneke, Isabelle; Ahrens, Theresa D.; Robaa, Dina; Wenzler, Sandra; Barthes, Nicolas P. F.; Franz, Henriette; Sipp, Wolfgang; Lassmann, Silke; Diederichs, Sven; Schleicher, Erik; Schofield, Christopher J.; Kawamura, Akane; Schuele, Roland; Jung, Manfred
err分享
err收藏
学者 查看更多内容